VT
INDV icon

Vise Technologies’s Indivior Pharmaceuticals INDV Stock Holding History

Vise Technologies’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
+6,992
New +$254K ﹤0.01% 1476
2026
Q1 		– Sell
-7,147
Closed -$256K – 1457
2025
Q4 		$256K Buy
+7,147
New +$218K 0.01% 1240

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vise Technologies's INDV Position: Q2 2026 in Review

Vise Technologies opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 6,992 shares worth $287K. The stake represents ﹤0.01% of the portfolio and ranks #1476 among its holdings. This is a return to the name: Vise Technologies previously reported a position in INDV as recently as Q4 2025.

Vise Technologies first reported a position in INDV in Q4 2025 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vise Technologies held 6,992 shares of Indivior Pharmaceuticals worth $287K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Vise Technologies position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Vise Technologies's portfolio in Q2 2026, its #1476 holding.
  • Vise Technologies first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.